TSXV: ATE       Antibe Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.39   +0.005 (1.30%)  0.38 - 0.40  975,412


Avg Volume (4 weeks):0
52 Weeks Range:0.38 - 0.72
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Antibe Therapeutics Inc is a healthcare company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen. The company has two primary business segments: Antibe Therapeutics, a pharmaceutical development company, and Citagenix, a marketer and distributor of regenerative medicines serving the dental and orthopedic marketplaces.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1314  1039  1321  478 

Top 10 Active Counters
 BTE 0.70+0.03 
 TSGI 37.49+0.36 
 ENB 40.15-0.05 
 BNS 55.54+1.41 
 TVI 0.020.00 
 PWF 36.31+0.31 
 TD 59.92+1.18 
 EHT 0.030.00 
 AQN 17.62+0.56 
 RY 93.08+1.81 
Partners & Brokers